Cite

HARVARD Citation

    Canini, L. et al. (2017). Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. Hepatology communications. 1 (4), pp. 288-292. [Online]. 
  
Back to record